{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T04:34:46Z","timestamp":1772685286641,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.neuroscience.2024.06.028","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T18:29:24Z","timestamp":1719512964000},"page":"152-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Alcohol drinking modified the effect of plasma YKL-40 levels on stroke-specific mortality of acute ischemic stroke"],"prefix":"10.1016","volume":"552","author":[{"given":"Ziyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongke","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengbao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinni","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bizhong","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.06.028_b0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/ane.12688","article-title":"Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke","volume":"136","author":"Chen","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cca.2020.09.035","article-title":"YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases","volume":"511","author":"Deng","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0025","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Diseases","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/sim.4780080504","article-title":"Flexible regression models with cubic splines","volume":"8","author":"Durrleman","year":"1989","journal-title":"Stat. Med."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/STROKEAHA.114.007624","article-title":"Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study","volume":"46","author":"Greisenegger","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.2013.282543","article-title":"Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: The CATIS randomized clinical trial","volume":"311","author":"He","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0050","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0168-8278(00)80095-1","article-title":"Serum YKL-40 is increased in patients with hepatic fibrosis","volume":"32","author":"Johansen","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/1055-9965.EPI-05-0011","article-title":"Serum YKL-40, a new prognostic biomarker in cancer patients?","volume":"15","author":"Johansen","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0060","unstructured":"Joint Committee for Developing Chinese guidelines on P, Treatment of Dyslipidemia in A. 2007. [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi 35, 390-419."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/STROKEAHA.114.007657","article-title":"Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population","volume":"46","author":"Kjaergaard","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10408363.2016.1190683","article-title":"Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases","volume":"53","author":"Kjaergaard","year":"2016","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13293-021-00393-0","article-title":"Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality","volume":"12","author":"Laucyte-Cibulskiene","year":"2021","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12974-022-02467-1","article-title":"Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study","volume":"19","author":"Li","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0085","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1161\/STROKEAHA.114.005380","article-title":"Associations between estimated glomerular filtration rate and stroke outcomes in diabetic versus nondiabetic patients","volume":"45","author":"Luo","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13098-021-00624-9","article-title":"Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"13","author":"Luo","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0095","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3390\/ijms22158102","article-title":"Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment","volume":"22","author":"Marozzi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0100","doi-asserted-by":"crossref","DOI":"10.4161\/biom.23863","article-title":"Hyaluronan, neural stem cells and tissue reconstruction after acute ischemic stroke","volume":"3","author":"Moshayedi","year":"2013","journal-title":"Biomatter"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8278(03)00184-3","article-title":"Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease","volume":"39","author":"Nojgaard","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/alcalc\/agu072","article-title":"Plasma YKL-40 in inuit and danes","volume":"50","author":"Nojgaard","year":"2015","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0115","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2014.09.033","article-title":"Alcohol directly stimulates epigenetic modifications in hepatic stellate cells","volume":"62","author":"Page","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051722","article-title":"Serum YKL-40 levels correlate with infarct volume, stroke severity, and functional outcome in acute ischemic stroke patients","volume":"7","author":"Park","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1524-6175.2005.04377.x","article-title":"Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee","volume":"7","author":"Pickering","year":"2005","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biopha.2018.02.050","article-title":"Angiogenic potential of YKL-40 in the dynamics of tumor niche","volume":"100","author":"Pouyafar","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0135","first-page":"1","article-title":"Independent predictive value of elevated YKL-40 in ischemic stroke prognosis: findings from a nationwide stroke registry","author":"Qin","year":"2023","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0140","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000897","article-title":"Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events","volume":"3","author":"Ridker","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2013.03.022","article-title":"Intake of traditional Inuit diet vary in parallel with inflammation as estimated from YKL-40 and hsCRP in Inuit and non-Inuit in Greenland","volume":"228","author":"Sch\u00e6bel","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fphys.2013.00122","article-title":"YKL-40 acts as an angiogenic factor to promote tumor angiogenesis","volume":"4","author":"Shao","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0155","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/1747493018798526","article-title":"Long-term neurological, vascular, and mortality outcomes after stroke","volume":"13","author":"Singh","year":"2018","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0160","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1253\/circj.CJ-18-0346","article-title":"Two-year survival after first-ever stroke in a general population of 1.4 million japanese - shiga stroke registry","volume":"82","author":"Takashima","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.neuroscience.2024.06.028_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12986-015-0007-4","article-title":"Association of alcohol consumption and components of metabolic syndrome among people in rural China","volume":"12","author":"Xiao","year":"2015","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0170","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004534","article-title":"YKL-40 Level and hypertension incidence: a population-based nested case-control study in China","volume":"5","author":"Xu","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.neuroscience.2024.06.028_b0175","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026263","article-title":"Plasma human cartilage glycoprotein-39 is associated with the prognosis of acute ischemic stroke","volume":"11","author":"Xu","year":"2022","journal-title":"J. Am. Heart Assoc."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224002859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224002859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T20:38:29Z","timestamp":1722026309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224002859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":34,"alternative-id":["S0306452224002859"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.06.028","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcohol drinking modified the effect of plasma YKL-40 levels on stroke-specific mortality of acute ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 IBRO. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}